First Time Loading...

Abcam PLC
LSE:ABC

Watchlist Manager
Abcam PLC Logo
Abcam PLC
LSE:ABC
Watchlist
Price: 1 226 GBX 11.15% Market Closed
Updated: Apr 29, 2024

Abcam PLC
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abcam PLC
Revenue Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Abcam PLC
LSE:ABC
Revenue
£350.4m
CAGR 3-Years
10%
CAGR 5-Years
10%
CAGR 10-Years
14%
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Revenue
$6.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Revenue
$1.7m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Revenue
$27m
CAGR 3-Years
37%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Revenue
£249.4m
CAGR 3-Years
102%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Revenue
£673.1m
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
6%

See Also

What is Abcam PLC's Revenue?
Revenue
350.4m GBP

Based on the financial report for Jun 30, 2022, Abcam PLC's Revenue amounts to 350.4m GBP.

What is Abcam PLC's Revenue growth rate?
Revenue CAGR 10Y
14%

Over the last year, the Revenue growth was 18%. The average annual Revenue growth rates for Abcam PLC have been 10% over the past three years , 10% over the past five years , and 14% over the past ten years .